BIODEXA Trademark

Trademark Overview


On Monday, September 4, 2023, a trademark application was filed for BIODEXA with the United States Patent and Trademark Office. The USPTO has given the BIODEXA trademark a serial number of 79380368. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 11, 2024. This trademark is owned by BIODEXA PHARMACEUTICALS LIMITED. The BIODEXA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals; 3D printing; custom 3D printing for others; 3D printing and custom 3D printing in the fields of pharmaceuticals and medicines; 3D printing and custom 3D printing in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid

Pharmaceutical and drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific research, design and analysis in the field of drug delivery; technological services in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid
biodexa

General Information


Serial Number79380368
Word MarkBIODEXA
Filing DateMonday, September 4, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals; 3D printing; custom 3D printing for others; 3D printing and custom 3D printing in the fields of pharmaceuticals and medicines; 3D printing and custom 3D printing in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid
Goods and ServicesPharmaceutical and drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific research, design and analysis in the field of drug delivery; technological services in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIODEXA PHARMACEUTICALS LIMITED
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressGB

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 5, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 14, 2023APPLICATION FILING RECEIPT MAILED
Thursday, November 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 30, 2024ASSIGNED TO EXAMINER
Tuesday, May 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 20, 2024REFUSAL PROCESSED BY MPU
Tuesday, June 11, 2024REFUSAL PROCESSED BY IB
Monday, May 20, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB